Advanced Biomed Inc. (ADVB)
Advanced Biomed will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
1,875,000
Deal Size
$9.38M
Advanced Biomed Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
38
Market Cap
109.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionADVB News
- 1 year ago - IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan - Seeking Alpha
- 1 year ago - Advanced Biomed sets IPO terms, which could value the biotech at up to $625 million - Market Watch
- 1 year ago - Advanced Biomed Begins $150 Million U.S. IPO Rollout - Seeking Alpha
- 1 year ago - Advanced Biomed IPO Registration Document (S-1) - SEC